- $150.41m
- $138.24m
- $26.77m
- 39
- 10
- 45
- 22
Annual balance sheet for Stereotaxis, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 30.2 | 43.9 | 38.7 | 28.4 | 19.8 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 5.33 | 3.52 | 5.41 | 5.09 | 3.82 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 38.8 | 52.7 | 51.4 | 43.2 | 33.3 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 4.54 | 2.43 | 8.37 | 9.21 | 8.29 |
Other Long Term Assets | |||||
Total Assets | 43.6 | 55.5 | 61 | 53.4 | 41.9 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 12.2 | 13.6 | 13.3 | 14.3 | 13.2 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 15.1 | 15.2 | 21.6 | 21.5 | 20 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Total Equity | 28.5 | 40.2 | 39.4 | 31.9 | 21.9 |
Total Liabilities & Shareholders' Equity | 43.6 | 55.5 | 61 | 53.4 | 41.9 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |